Ameriprise’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $643M | Buy |
8,954,534
+903,330
| +11% | +$69.6M | 0.15% | 145 |
|
|
2025
Q4 | $639M | Sell |
8,051,204
-397,216
| -5% | -$31.3M | 0.14% | 140 |
|
|
2025
Q3 | $637M | Buy |
8,448,420
+592,575
| +8% | +$40.6M | 0.15% | 148 |
|
|
2025
Q2 | $542M | Buy |
7,855,845
+385,806
| +5% | +$25.3M | 0.13% | 164 |
|
|
2025
Q1 | $506M | Buy |
7,470,039
+148,546
| +2% | +$8.89M | 0.14% | 163 |
|
|
2024
Q4 | $329M | Buy |
7,321,493
+639,325
| +10% | +$35.9M | 0.08% | 238 |
|
|
2024
Q3 | $420M | Sell |
6,682,168
-65,525
| -1% | -$3.82M | 0.11% | 206 |
|
|
2024
Q2 | $399M | Buy |
6,747,693
+3,214,927
| +91% | +$201M | 0.11% | 200 |
|
|
2024
Q1 | $282M | Sell |
3,532,766
-1,208,995
| -25% | -$92.4M | 0.08% | 265 |
|
|
2023
Q4 | $376M | Sell |
4,741,761
-1,561,438
| -25% | -$111M | 0.11% | 196 |
|
|
2023
Q3 | $441M | Sell |
6,303,199
-2,474,949
| -28% | -$175M | 0.14% | 157 |
|
|
2023
Q2 | $608M | Buy |
8,778,148
+128,445
| +1% | +$9.14M | 0.19% | 113 |
|
|
2023
Q1 | $640M | Sell |
8,649,703
-2,827,356
| -25% | -$237M | 0.21% | 114 |
|
|
2022
Q4 | $1.07B | Sell |
11,477,059
-3,698,054
| -24% | -$357M | 0.37% | 57 |
|
|
2022
Q3 | $1.45B | Sell |
15,175,113
-509,974
| -3% | -$50.5M | 0.54% | 28 |
|
|
2022
Q2 | $1.45B | Buy |
15,685,087
+1,262,093
| +9% | +$123M | 0.5% | 32 |
|
|
2022
Q1 | $1.45B | Buy |
14,422,994
+897,241
| +7% | +$94.3M | 0.43% | 40 |
|
|
2021
Q4 | $1.37B | Buy |
13,525,753
+2,963,269
| +28% | +$274M | 0.38% | 47 |
|
|
2021
Q3 | $896M | Buy |
10,562,484
+1,977,119
| +23% | +$166M | 0.29% | 67 |
|
|
2021
Q2 | $721M | Buy |
8,585,365
+485,427
| +6% | +$39.8M | 0.22% | 94 |
|
|
2021
Q1 | $610M | Buy |
8,099,938
+301,497
| +4% | +$22M | 0.2% | 109 |
|
|
2020
Q4 | $533M | Buy |
7,798,441
+3,566,284
| +84% | +$232M | 0.19% | 111 |
|
|
2020
Q3 | $245M | Sell |
4,232,157
-62,471
| -1% | -$3.89M | 0.1% | 219 |
|
|
2020
Q2 | $278M | Buy |
4,294,628
+846,516
| +25% | +$53.3M | 0.12% | 185 |
|
|
2020
Q1 | $205M | Buy |
3,448,112
+159,033
| +5% | +$10.6M | 0.11% | 199 |
|
|
2019
Q4 | $245M | Buy |
3,289,079
+1,072,122
| +48% | +$75.3M | 0.1% | 205 |
|
|
2019
Q3 | $140M | Buy |
2,216,957
+233,704
| +12% | +$13.8M | 0.06% | 300 |
|
|
2019
Q2 | $108M | Sell |
1,983,253
-1,429,097
| -42% | -$77M | 0.05% | 401 |
|
|
2019
Q1 | $184M | Sell |
3,412,350
-2,316,786
| -40% | -$143M | 0.08% | 249 |
|
|
2018
Q4 | $375M | Buy |
5,729,136
+1,187,965
| +26% | +$88.7M | 0.19% | 108 |
|
|
2018
Q3 | $383M | Buy |
4,541,171
+1,965,071
| +76% | +$140M | 0.13% | 176 |
|
|
2018
Q2 | $166M | Sell |
2,576,100
-3,793,854
| -60% | -$250M | 0.07% | 270 |
|
|
2018
Q1 | $396M | Sell |
6,369,954
-4,187,393
| -40% | -$300M | 0.18% | 125 |
|
|
2017
Q4 | $765M | Buy |
10,557,347
+2,579,977
| +32% | +$188M | 0.35% | 58 |
|
|
2017
Q3 | $649M | Buy |
7,977,370
+1,849,593
| +30% | +$146M | 0.31% | 69 |
|
|
2017
Q2 | $493M | Sell |
6,127,777
-1,873,867
| -23% | -$148M | 0.25% | 91 |
|
|
2017
Q1 | $628M | Sell |
8,001,644
-2,025,267
| -20% | -$162M | 0.33% | 63 |
|
|
2016
Q4 | $791M | Sell |
10,026,911
-3,781,327
| -27% | -$306M | 0.43% | 41 |
|
|
2016
Q3 | $1.23B | Sell |
13,808,238
-1,268,736
| -8% | -$120M | 0.69% | 23 |
|
|
2016
Q2 | $1.44B | Sell |
15,076,974
-2,456,170
| -14% | -$245M | 0.85% | 17 |
|
|
2016
Q1 | $1.82B | Sell |
17,533,144
-2,210,310
| -11% | -$215M | 1.09% | 10 |
|
|
2015
Q4 | $1.93B | Sell |
19,743,454
-732,701
| -4% | -$71.8M | 1.13% | 7 |
|
|
2015
Q3 | $1.98B | Buy |
20,476,155
+1,015,803
| +5% | +$107M | 1.22% | 6 |
|
|
2015
Q2 | $2.04B | Buy |
19,460,352
+4,907,205
| +34% | +$501M | 1.16% | 4 |
|
|
2015
Q1 | $1.5B | Buy |
14,553,147
+984,415
| +7% | +$99.6M | 0.86% | 9 |
|
|
2014
Q4 | $1.31B | Buy |
13,568,732
+321,851
| +2% | +$28.4M | 0.76% | 16 |
|
|
2014
Q3 | $1.05B | Buy |
13,246,881
+1,130,983
| +9% | +$89.2M | 0.63% | 22 |
|
|
2014
Q2 | $913M | Buy |
12,115,898
+82,167
| +0.7% | +$6.21M | 0.54% | 24 |
|
|
2014
Q1 | $901M | Buy |
12,033,731
+2,081,617
| +21% | +$147M | 0.54% | 24 |
|
|
2013
Q4 | $712M | Buy |
9,952,114
+535,481
| +6% | +$34.4M | 0.43% | 40 |
|
|
2013
Q3 | $534M | Buy |
9,416,633
+1,214,560
| +15% | +$72.4M | 0.35% | 53 |
|
|
2013
Q2 | $469M | Buy |
+8,202,073
| New | +$475M | 0.32% | 58 |
|
Other funds holding CVS
VCM
VPM
Ameriprise's CVS Position: Q1 2026 in Review
Ameriprise increased its CVS Health (CVS) stake by 11% in Q1 2026, buying an estimated $69.6M and bringing the position to 8,954,534 shares worth $643M. The position accounts for 0.15% of the portfolio, ranked #145.
Ameriprise first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.04B in Q2 2015. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Ameriprise held 8,954,534 shares of CVS Health worth $643M as of Q1 2026.
- Ameriprise bought 903,330 CVS Health shares in Q1 2026, an estimated $69.6M.
- CVS Health made up 0.15% of Ameriprise's portfolio in Q1 2026, its #145 holding.
- Ameriprise first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's CVS Health position peaked at $2.04B in Q2 2015.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.